Why is brivaracetam not recommended for long-term use and precautions

Brivaracetam (Brivaracetam) is a new generation of anti-epileptic drugs, mainly suitable for the adjuvant treatment of adults and adolescent patients over 16 years old with partial seizures (focal seizures). It is a structural analog of levetiracetam (Levetiracetam). It also binds to the synaptic vesicle protein SV2A to regulate neurotransmitter release, thereby exerting anti-epileptic effects. However, although Brivaracetam has shown good clinical efficacy and tolerability, there are still some potential risks, so long-term use requires extreme caution. The following content will comprehensively explain the pharmacological effects, reasons why long-term use is not recommended, adverse reactions, precautions for use, etc.

1. Pharmacological mechanism and action advantages

Brivaracetam binds to SV2A protein with high affinity, stabilizing neuronal excitability and preventing the spread of epileptic discharges. Compared with levetiracetam, brivaracetam has the advantages of rapid onset of action, strong ability to penetrate the blood-brain barrier, and weak sedative effect. At the same time, Brivaracetam has almost no effect on the GABAergic and glutamatergic systems, and theoretically has fewer side effects, especially milder adverse effects on mood and cognition.

In addition, brivaracetam has few drug interactions with other anti-epileptic drugs, is metabolized mainly through the liverCYP2C19 enzyme system, and has a simple excretion method, making it suitable for most patients with epilepsy, especially those who have failed to respond to traditional treatments.

2. Reasons why long-term use is not recommended

Although the short-term efficacy of Brivaracetam is clear, the following factors make it unsuitable for long-term use in some cases:

Cumulative psychiatric and neurological side effects: Long-term use of brivaracetam may lead to mood swings, anxiety, depression and even aggressive behavior. Some patients report hallucinations, agitation, and suicidal thoughts. These mental symptoms may gradually worsen during long-term medication, especially in those with a history of mental illness.

Tolerance and decreased efficacy: As with other anti-epileptic drugs, some patients may experience a gradual weakening of efficacy after long-term use of brivaracetam. Although the mechanism of drug resistance is not yet fully understood, the decreased drug response caused by individual differences still requires attention.

Hepatic metabolism burden: Although Brivaracetam is metabolized relatively clearly, long-term use may burden liver function. In particular, patients who use other drugs in combination should pay attention to side effects such as increased liver enzymes. Chronic users should regularly monitor liver function indicators.

Long-term dependence and drug withdrawal reactions: Long-term use of brivaracetam may cause patients to become dependent on it. Once the drug is stopped suddenly, it may easily lead to recurrence of epilepsy or "discontinuation syndrome", which manifests as severe headache, irritability, insomnia and other rebound symptoms.

3. Common adverse reactions and monitoring recommendations

Common adverse reactions of brivaracetam include headache, drowsiness, fatigue, nausea, dizziness, respiratory infection, etc. Some patients may experience elevated liver enzymes, mood disorders, or mild cognitive decline. Similar to levetiracetam, but with a slightly lower overall incidence of psychiatric side effects.

While using brivaracetam you should:

Monitor liver function every3-6 months (ALT, AST)

Observe changes in mood and behavior, especially in teenagers

Establish good communication with patients and their families. Once depression or self-harm tendencies occur, they must be dealt with promptly.

4. Medication precautions and substitution suggestions

Individualized treatment: The recommended dose of brivaracetam is generally 100mg~200mg per day, divided into 2 times. Some patients can adjust to 400mg/day according to the efficacy, but the dose should be gradually increased and tolerance should be observed.

Medication for special groups: children, the elderly or those with liver damage should use it at a reduced dosage. Breast-feeding women should use with caution. Pregnant women should use it after weighing the pros and cons.

Principle of gradual discontinuation: It is not recommended to stop brivaracetam suddenly, especially for long-term users. Medication should be discontinued and the dose should be gradually reduced under the guidance of a doctor to avoid recurrence of epilepsy.

Alternative drugs that can be considered: If the efficacy of brivaracetam decreases or the side effects are intolerable after long-term use, you can discuss with your doctor about switching to other drugs, such as levetiracetam, lamotrigine, topiramate, clonazepam, etc., and choose an appropriate plan according to the type of epilepsy and individual conditions.

Brivaracetam is a new drug with clear efficacy in the treatment of focal epilepsy, especially for patients who are insensitive to other drugs. However, long-term use still faces problems such as the risk of drug resistance, psychiatric side effects, and metabolic burden. Therefore, brivaracetam is more suitable as a staged option for short- to medium-term treatment, or as a transitional solution when other treatments are ineffective.

In clinical application, the principle of "individualized + dynamic evaluation" should be adhered to, and attention should be paid to the balance between drug efficacy and side effects. Doctors need to regularly evaluate the efficacy and patients' mental state, and patients also need to proactively provide feedback on their medication experience to ensure safe, effective, and long-term control of epileptic seizures.

Reference materials:https://www.drugs.com/

xa0